Fourth Dimension Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99M Buy
2,496
+282
+13% +$288K 0.95% 29
2026
Q1
$2.04M Sell
2,214
-120
-5% -$122K 0.77% 33
2025
Q4
$2.51M Hold
2,334
0.92% 31
2025
Q3
$1.78M Sell
2,334
-52
-2% -$38.7K 0.68% 39
2025
Q2
$1.86M Buy
2,386
+808
+51% +$628K 0.79% 36
2025
Q1
$1.3M Buy
1,578
+318
+25% +$265K 0.63% 39
2024
Q4
$973K Buy
+1,260
New +$1.04M 0.51% 39

Other funds holding LLY

Fourth Dimension Wealth's LLY Position: Q2 2026 in Review

Fourth Dimension Wealth increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $288K and bringing the position to 2,496 shares worth $2.99M. The position accounts for 0.95% of the portfolio, ranked #29.

Fourth Dimension Wealth first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fourth Dimension Wealth held 2,496 shares of Eli Lilly worth $2.99M as of Q2 2026.
  • Fourth Dimension Wealth bought 282 Eli Lilly shares in Q2 2026, an estimated $288K.
  • Eli Lilly made up 0.95% of Fourth Dimension Wealth's portfolio in Q2 2026, its #29 holding.
  • Fourth Dimension Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.